Physician

Myo Min, MD

According to 2025 Medicare claims, Myo Min, MD (NPI: 1740274315) practices hematology/oncology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Harford, MD. This provider's primary affiliated billing organization is UPPER CHESAPEAKE HEMATOLOGY AND ONCOLOGY SERVICES, LLC (NPI: 1699067058; TIN: 275156680) and primary practice location at 21001-2682. Min is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Min's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 721 traditional Medicare patients, billed 159,267 HCPCS/CPT codes, and received $4,652,125 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 939 prescription claims across 194 beneficiaries totaling $2,235,804 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 22 claims. Open Payments data shows 9 records totaling $197. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,054,793 to $4,652,125. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,056 to $1,461.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	978	68,372	$1,054,793
2016	952	57,166	$1,063,379
2017	942	52,046	$1,122,781
2018	1,061	85,155	$1,519,159
2019	1,085	82,502	$1,318,467
2020	882	58,613	$1,014,824
2021	863	73,766	$1,441,560
2022	811	84,351	$1,985,319
2023	761	113,072	$2,760,261
2024	721	159,267	$4,652,125

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	161	926	$1,667,446
2016	196	1,082	$2,223,893
2017	171	1,005	$2,217,643
2018	203	1,240	$3,157,234
2019	179	1,118	$4,095,456
2020	155	980	$3,846,406
2021	178	1,052	$4,715,996
2022	162	761	$3,418,555
2023	153	643	$1,828,450
2024	194	939	$2,235,804

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	158	$71,388
2016	N/R	94	$28,743
2017	12	132	$29,511
2018	24	139	$13,914
2019	12	141	$11,020
2020	N/R	131	$9,915
2021	N/R	74	$4,736
2022	N/R	64	$2,095
2023	N/R	52	$10,262
2024	N/R	22	$874

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	97	152	$145
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	115	128	$139
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	515	1,195	$97
36415	Insertion of needle into vein for collection of blood sample	408	871	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	411	1,215	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	37	1,110	$529,750
Venclexta	Venetoclax	23	562	$260,558
Ibrance	Palbociclib	12	336	$181,120
Imatinib Mesylate	Imatinib Mesylate	19	630	$44,742
Eliquis	Apixaban	30	1,380	$26,621

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	11	$724
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	11	$150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$197	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Myo Min, MD?

Tedicare shows public-source Medicare data for Myo Min, MD (NPI 1740274315), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Myo Min, MD have ACO affiliation data?

Myo Min, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Myo Min, MD?

Myo Min, MD is linked to UPPER CHESAPEAKE HEMATOLOGY AND ONCOLOGY SERVICES, LLC (billing NPI 1699067058) in the available physician profile data.

Does Myo Min, MD have Open Payments data?

Myo Min, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.